BRIEF published on 12/17/2025 at 11:02, 9 months 12 days ago Valerio Therapeutics Appoints Professor Eric Vivier as Board Observer Board Of Directors Immunology Valerio Therapeutics Professor Eric Vivier Oncology Strategy
BRIEF published on 12/17/2025 at 11:02, 9 months 12 days ago Valerio Therapeutics nomme le professeur Eric Vivier observateur au conseil d'administration Conseil D'administration Valerio Thérapeutique Immunologie Professeur Eric Vivier Stratégie En Oncologie
BRIEF published on 12/17/2025 at 11:02, 9 months 12 days ago Valerio Therapeutics Welcomes Professor Eric Vivier to its Board of Directors Board Of Directors Oncology Immunology Valerio Therapeutics Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 9 months 12 days ago Valerio Therapeutics Accueille le Professeur Eric Vivier au Conseil d'Administration Conseil D'administration Oncologie Valerio Therapeutics Immunologie Eric Vivier
PRESS RELEASE published on 12/17/2025 at 10:57, 9 months 12 days ago Inside Information / Other news releases Valerio Therapeutics appoints Prof. Eric Vivier as Observer to Board of Directors. Prof. Vivier, a renowned immunologist, will bring over 30 years of experience to drive innovative tumor treatment approaches Board Of Directors Valerio Therapeutics Professor Eric Vivier Immunologist Tumor Treatment
PRESS RELEASE published on 12/17/2025 at 10:57, 9 months 12 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce la désignation du Professeur Eric Vivier en qualité d'Observateur de son Conseil d’Administration. Le Professeur apportera son expertise en immunologie pour développer des traitements innovants en oncologie Conseil D'administration Valerio Therapeutics Immunologie Professeur Eric Vivier Observateur
PRESS RELEASE published on 10/30/2025 at 09:05, 10 months 30 days ago Half-Year Financial Report 2025
PRESS RELEASE published on 10/30/2025 at 09:04, 10 months 30 days ago Rapport financier semestriel 2025
BRIEF published on 10/30/2025 at 09:03, 10 months 30 days ago Valerio Therapeutics' financial and strategic review for the first half of 2025 Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
BRIEF published on 10/30/2025 at 09:03, 10 months 30 days ago Bilan financier et stratégique de Valerio Therapeutics pour le 1er semestre 2025 Recentrage Stratégique Valerio Therapeutics Résultats Financiers 2025 Plateformes V-Body Recherche Partenariats
Published on 09/29/2026 at 23:00, 14 minutes ago Abasca Resources Closes Non-Brokered Private Placement of $2.25 Million
Published on 09/29/2026 at 22:15, 59 minutes ago CANEX Closes Oversubscribed $9.5 Million Equity Financing
Published on 09/29/2026 at 22:00, 1 hour 14 minutes ago Rocky Shore Closes Springdale Property Acquisition and Completes Initial Payments Under the Handcamp Property Option Agreement
Published on 09/29/2026 at 16:45, 6 hours 29 minutes ago Gold Terra Announces Visible Mineralization in Hole CMUP-005 in Early Sonic Drilling at the Con Mine Historical Tailings, Yellowknife, NWT
Published on 09/29/2026 at 21:30, 1 hour 44 minutes ago Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Published on 09/29/2026 at 19:47, 3 hours 27 minutes ago EQS-Adhoc: Marley Spoon Group SE: MARLEY SPOON GROUP SE REPORTS H1 2026 RESULTS AND GUIDANCE FOR 2026
Published on 09/29/2026 at 19:15, 3 hours 59 minutes ago Pensão Amor: Discover Lisbon's Most Surprising Hotel
Published on 09/29/2026 at 19:14, 4 hours ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 19:14, 4 hours ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 17:40, 5 hours 34 minutes ago Infotel : Mise à disposition du rapport financier semestriel 2026.
Published on 09/29/2026 at 17:40, 5 hours 34 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 31.08.26.
Published on 09/29/2026 at 14:15, 8 hours 59 minutes ago 260929 BENETEAU Mise en oeuvre du programme de rachat d'actions
